Published in Arab J Urol on January 10, 2013
Consensus statement on management of intersex disorders. International Consensus Conference on Intersex. Pediatrics (2006) 4.40
Sex determination and differentiation. N Engl J Med (2004) 3.07
Mullerian inhibiting substance in humans: normal levels from infancy to adulthood. J Clin Endocrinol Metab (1996) 2.37
How should we classify intersex disorders? J Pediatr Urol (2010) 2.29
Ambiguous genitalia with perineoscrotal hypospadias in 46,XY individuals: long-term medical, surgical, and psychosexual outcome. Pediatrics (2002) 2.26
Prenatal sex hormone effects on child and adult sex-typed behavior: methods and findings. Neurosci Biobehav Rev (2005) 2.26
Phenotypic features, androgen receptor binding, and mutational analysis in 278 clinical cases reported as androgen insensitivity syndrome. J Clin Endocrinol Metab (2000) 1.74
WT1 and glomerular diseases. Pediatr Nephrol (2006) 1.68
A case of clear cell adenocarcinoma of the müllerian duct in persistent müllerian duct syndrome: the first reported case. Am J Surg Pathol (2002) 1.64
Disorders of sex differentiation: a pediatric urologist's perspective of new terminology and recommendations. J Urol (2010) 1.58
Frasier syndrome is caused by defective alternative splicing of WT1 leading to an altered ratio of WT1 +/-KTS splice isoforms. Hum Mol Genet (1998) 1.58
Long-term followup and comparison between genotype and phenotype in 29 cases of complete androgen insensitivity syndrome. J Urol (2008) 1.50
Gender change in 46,XY persons with 5alpha-reductase-2 deficiency and 17beta-hydroxysteroid dehydrogenase-3 deficiency. Arch Sex Behav (2005) 1.50
Gender identity outcome in female-raised 46,XY persons with penile agenesis, cloacal exstrophy of the bladder, or penile ablation. Arch Sex Behav (2005) 1.30
Sex-typed toy play behavior correlates with the degree of prenatal androgen exposure assessed by CYP21 genotype in girls with congenital adrenal hyperplasia. J Clin Endocrinol Metab (2002) 1.17
Phenotypic spectrum of mutations in DAX-1 and SF-1. Mol Cell Endocrinol (2001) 1.11
Carcinoma in situ in the testis. Scand J Urol Nephrol Suppl (2000) 1.05
Genital anomalies in human and animal models reveal the mechanisms and hormones governing testicular descent. Br J Urol (1997) 0.95
The genetics of male undermasculinization. Clin Endocrinol (Oxf) (2002) 0.94
Embryonic testicular regression sequence: a part of the clinical spectrum of 46,XY gonadal dysgenesis. Am J Med Genet (1994) 0.93
Revealing the diagnosis of androgen insensitivity syndrome in adulthood. BMJ (2005) 0.91
Sex with two SOX on: SRY and SOX9 in testis development. Trends Endocrinol Metab (2002) 0.89
Congenital adrenal hyperplasia: an update in children. Curr Opin Endocrinol Diabetes Obes (2011) 0.88
Intersexuality and gender identity differentiation. J Pediatr Adolesc Gynecol (2002) 0.86
Congenital adrenal hyperplasia: phenotype and genotype. J Pediatr Endocrinol Metab (2002) 0.84
The clinical and genetic heterogeneity of mixed gonadal dysgenesis: does "disorders of sexual development (DSD)" classification based on new Chicago consensus cover all sex chromosome DSD? Eur J Pediatr (2012) 0.82
Congenital adrenal hyperplasia: molecular genetics and alternative approaches to treatment. Adv Pediatr (1995) 0.80
The clinical spectrum and treatment of ovotesticular disorder of sexual development. Adv Exp Med Biol (2011) 0.77
Disorders of sexual differentiation: II. Diagnosis and treatment. Arab J Urol (2013) 0.79